标新生物

Circle Pharma is a biotechnology company focused on developing cell-permeable macrocyclic peptides against therapeutic targets using computational design and synthetic chemistry.In January 2016, Circle relocated to office and laboratory space in South San Francisco, CA.In June 2021, the company raised USD 66 million in an oversubscribed Series C financing.In March 2020, the company had raised USD 45 million in a series B financing round.In December 2016, the company issued USD 4.5 million shares of Series A preferred stock in a Series A financing round. In April 2017, the series A financing comprised of USD 6.5 million shares of series A preferred stock, was closed.In January 2016, the company extended its seed funding round with an investment from ShangPharma Investment Group

Gluetacs Therapeutics is a pharmaceutical company focused on protein degradation technology

Foghorn Therapeutics Inc.成立于2015年10月。该公司率先发现并开发了一类针对染色质调节系统内基因决定依赖性的药物，这是一个尚未开发的治疗机会干预。该公司专有的基因流量控制平台为其提供了一个对染色质调节系统的各个组成部分如何相互作用的综合性、机械性理解，使其能够识别、验证系统内的潜在药物靶点。